2CNL image
Entry Detail
PDB ID:
2CNL
Title:
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2006-05-22
Release Date:
2007-05-22
Method Details:
Experimental Method:
Resolution:
1.67 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CASPASE-3 SUBUNIT P17
Chain IDs:A
Chain Length:147
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:CASPASE-3 SUBUNIT P12
Chain IDs:B
Chain Length:103
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:AZA-PEPTIDE EPOXIDE
Chain IDs:C (auth: I)
Chain Length:5
Number of Molecules:1
Biological Source:SYNTHETIC CONSTRUCT
Peptide-like Molecules
PRD_000672
Primary Citation
Exploring the S4 and S1 Prime Subsite Specificities in Caspase-3 with Aza-Peptide Epoxide Inhibitors
Biochemistry 45 9059 ? (2006)
PMID: 16866351 DOI: 10.1021/BI060364P

Abstact

Caspase-3 is a prototypic executioner caspase that plays a central role in apoptosis. Aza-peptide epoxides are a novel class of irreversible inhibitors that are highly specific for clan CD cysteine proteases. The five crystal structures of caspase-3-aza-peptide epoxide inhibitor complexes reported here reveal the structural basis for the mechanism of inhibition and the specificities at the S1' and the S4 subsites. Unlike the clan CA cysteine proteases, the catalytic histidine in caspase-3 plays a critical role during protonation and subsequent ring opening of the epoxide moiety and facilitates the nucleophilic attack by the active site cysteine. The nucleophilic attack takes place on the C3 carbon atom of the epoxide and results in an irreversible alkylation of the active site cysteine residue. A favorable network of hydrogen bonds involving the oxyanion hole, catalytic histidine, and the atoms in the prime site of the inhibitor enhance the binding affinity and specificity of the aza-peptide epoxide inhibitors toward caspase-3. The studies also reveal that subtle movements of the N-terminal loop of the beta-subunit occur when the P4 Asp is replaced by a P4 Ile, whereas the N-terminal loop and the safety catch Asp179 are completely disordered when the P4 Asp is replaced by P4 Cbz group.

Legend

Protein

Chemical

Disease